Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Nov 26, 2024 | 12.60 | -2.85 |
Oak Valley Bancorp | OVLY | Nov 26, 2024 | 30.97 | -1.37 |
Oak Woods Acquisition | OAKU | Nov 26, 2024 | 11.25 | -0.97 |
Oaktree Acquisition III Life Sciences Unit | OACCU | Nov 26, 2024 | 10.10 | 0.00 |
Oaktree Capital A Pref | OAK-A | Nov 26, 2024 | 23.52 | -0.61 |
Oaktree Capital Group B Pref | OAK-B | Nov 26, 2024 | 22.89 | -0.32 |
Oaktree Specialty | OCSL | Nov 26, 2024 | 16.00 | -0.12 |
Oatly ADR | OTLY | Nov 26, 2024 | 0.72 | -2.35 |
Oblong | OBLG | Nov 26, 2024 | 3.53 | +1.44 |
Occidental Petroleum | OXY | Nov 26, 2024 | 49.85 | -1.17 |
Ocean Biomedical | OCEA | Nov 26, 2024 | 0.73 | +3.86 |
Ocean Power Technologies | OPTT | Nov 26, 2024 | 0.29 | +63.07 |
Oceaneering International | OII | Nov 26, 2024 | 29.29 | -1.71 |
OceanFirst Financial | OCFC | Nov 26, 2024 | 21.15 | -0.56 |
OceanFirst Pref | OCFCP | Nov 26, 2024 | 25.20 | 0.00 |
OceanPal | OP | Nov 26, 2024 | 1.42 | -1.04 |
Ocugen | OCGN | Nov 26, 2024 | 0.91 | -1.47 |
Ocular Therapeutix | OCUL | Nov 26, 2024 | 9.75 | +7.26 |
Oculis | OCS | Nov 26, 2024 | 15.37 | +3.92 |
Ocuphire Pharma | OCUP | Nov 26, 2024 | 1.17 | 0.00 |
Oddity Tech | ODD | Nov 26, 2024 | 46.81 | -2.58 |
Odyssey Marine Exploration | OMEX | Nov 26, 2024 | 0.37 | -1.46 |
Offerpad Solutions A | OPAD | Nov 26, 2024 | 4.13 | -0.24 |
Office Properties | OPI | Nov 26, 2024 | 1.72 | +4.24 |
OFG Bancorp | OFG | Nov 26, 2024 | 46.12 | -1.28 |
OFS Capital | OFS | Nov 26, 2024 | 8.12 | 0.00 |
OFS Credit | OCCI | Nov 26, 2024 | 7.10 | -0.56 |
OFS Credit C Pref | OCCIO | Nov 26, 2024 | 24.66 | -0.64 |
OFS Credit Company Pref F | OCCIM | Nov 26, 2024 | 24.96 | 0.00 |
OFS Credit E Pref | OCCIN | Nov 26, 2024 | 23.85 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.